• Toggle Accessibility Statement
  • Home
  • Skip to Main Content
  • Sitemap
×
  • Home
  • HTA Governance
    • Universal Health Care Act
    • Administrative Order on HTA
    • Philippine HTA Process Guide
    • Philippine HTA Methods Guide
      • Methods Guide for Clinical Equipment and Devices
      • Guidance Document for the Use of Real-World Evidence
    • Philippine HTA Code of Conduct
  • About Us
    • Mission/Vision
    • Health Technology Assessment Council (HTAC)
    • Health Technology Assessment Division (HTAD)
    • Road to HTA Institutionalization
    • External Partners
  • Publications
    • Omnibus HTA Tracker
    • HTA Topic Priority Lists
      • HTA TOPIC PRIORITY LIST (Cycle 1)
      • HTA TOPIC PRIORITY LIST (Cycle 2)
    • Assessments
    • Evidence Briefs
    • Issuances
    • Events and Press Releases
    • Annual Reports
      • 2023 Annual Report
      • 2022 Annual Report
      • 2021 Annual Report
      • 2020 Annual Report
      • 2019 Annual Report
    • FAQs on HTA
  • Get Involved with Us
    • Topic Nomination
    • Call for Proposals
    • Appeals
    • Careers
    • Contact Us
  • AUXILIARY MENU
Menu
GOVPH
  • GOVPH
  • Home
  • HTA Governance
    • Universal Health Care Act
    • Administrative Order on HTA
    • Philippine HTA Process Guide
    • Philippine HTA Methods Guide
      • Methods Guide for Clinical Equipment and Devices
      • Guidance Document for the Use of Real-World Evidence
    • Philippine HTA Code of Conduct
  • About Us
    • Mission/Vision
    • Health Technology Assessment Council (HTAC)
    • Health Technology Assessment Division (HTAD)
    • Road to HTA Institutionalization
    • External Partners
  • Publications
    • Omnibus HTA Tracker
    • HTA Topic Priority Lists
      • HTA TOPIC PRIORITY LIST (Cycle 1)
      • HTA TOPIC PRIORITY LIST (Cycle 2)
    • Assessments
    • Evidence Briefs
    • Issuances
    • Events and Press Releases
    • Annual Reports
      • 2023 Annual Report
      • 2022 Annual Report
      • 2021 Annual Report
      • 2020 Annual Report
      • 2019 Annual Report
    • FAQs on HTA
  • Get Involved with Us
    • Topic Nomination
    • Call for Proposals
    • Appeals
    • Careers
    • Contact Us
    • Accessibility Statement
    • High Contrast
    • Skip to Content
    • Skip to Footer
    • Default Text Size
    • Reduce Text Size - -
    • Enlarge Text Size + +

DOST - Health Technology Assessment Official Logo
Republic of the Philippines
DOST - Health Technology Assessment

Philippine Standard Time:

Evidence brief for 10 to 16 December 2022

Posted on December 21, 2022

For the period of  10 to 16 December 2022 Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD) Document Link: 10 – 16 December 2022 Document Preview:

[Department Circular No. 2022 – 0625] Health Technology Assessment Council (HTAC) Recommendation for the Inclusion of Abiraterone Acetate and Non-Inclusion of Enzalutamide for Individuals with Metastatic Castration-Resistant Prostate Cancer in the Philippine National Formulary (PNF)

Posted on December 15, 2022

Evidence brief for 03 to 09 December 2022

Posted on December 14, 2022

For the period of  03 to 09 December 2022 Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD)  Document Link: 03 – 09 December 2022 Document Preview:

[Department Memorandum No. 2022 – 0545] Interim Guidelines on the Process and Methods for the Selection of Medical Devices for Inclusion in the Philippine Essential Medical Device List (PEMDL)

Posted on December 14, 2022

[Advisory] Publication of the Guidelines on the Application of the Philippine Social Values on the Health Technology Assessment (HTA)

Posted on December 13, 2022

Post navigation

← Older posts
Newer posts →